Evaluation of clinical efficacy and safety of norbolethone in the treatment of idiopathic underweight.
D000293:Adolescent; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects*; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D008598:Menstruation / Q000187:drug effects
D045930:Anabolic Agents